Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.

导出原文传递

翻译打印收藏纠错

作者： Chika,Igarashi ^[1] ; Yukie,Yoshii ^[1] ; Hideaki,Tashima ^[2] ; Yuma,Iwao ^[2] ; Kohei,Sakurai ^[1] ; Fukiko,Hihara ^[1] ; Tomoko,Tachibana ^[1] ; Eiji,Yoshida ^[1] ; Hidekatsu,Wakizaka ^[2] ; Go,Akamatsu ^[2] ; Taiga,Yamaya ^[2] ; Mitsuyoshi,Yoshimoto ^[3] ; Hiroki,Matsumoto ^[1] ; Ming-Rong,Zhang ^[2] ; Kotaro,Nagatsu ^[2] ; Aya,Sugyo ^[1] ; Atsushi B,Tsuji ^[1] ; Tatsuya,Higashi ^[1]

作者单位： Department of Molecular Imaging and Theranostics. ^[1] Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, Chiba. ^[2] Division of Functional Imaging, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan. ^[3]

DOI 10.1097/MNM.0000000000001442

PMID 34100794

发布时间 2024-07-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Nuclear medicine communications

2021年42卷10期

1112-1121页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.

Nuclear medicine communications

相似文献

Nuclear medicine communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.

Nuclear medicine communications

相似文献

Nuclear medicine communications

相关期刊

检索历史清除